Search research articles
Contact Us
Filters
Showing results (521-530 of 612) with videos related to
Page
of 62
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2008
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report
Susan L Cohn, Andrew D J Pearson, Wendy B London, et al.
Pediatric Blood & Cancer
|
February 12, 2016
Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin-Embedded Tissue Samples and Are Associated With Recurrence
Navin Pinto, Jodi R Mayfield, Gordana Raca, et al.
Epidemiology (Cambridge, Mass.)
|
January 4, 2001
Residential pesticide exposure and neuroblastoma
J L Daniels, A F Olshan, K Teschke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 26, 2015
Advances in Risk Classification and Treatment Strategies for Neuroblastoma
Navin R Pinto, Mark A Applebaum, Samuel L Volchenboum, et al.
The Oncologist
|
February 18, 2017
A Phase II Randomized Trial (GO27827) of First-Line FOLFOX Plus Bevacizumab with or Without the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer
Johanna C Bendell, Howard Hochster, Lowell L Hart, et al.
Journal of Pain and Symptom Management
|
May 4, 2020
Racial and Ethnic Differences in Communication and Care for Children With Advanced Cancer
Jennifer W Mack, Hajime Uno, Clare J Twist, et al.
Clinical Pharmacology and Therapeutics
|
February 20, 2014
Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients
N Pinto, E R Gamazon, N Antao, et al.
Pediatric Blood & Cancer
|
December 19, 2013
Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: a report from the Children's Oncology Group (ANBL0621)
Elizabeth Fox, Yael P Mosse', Holly M Meany, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2008
The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report
Tom Monclair, Garrett M Brodeur, Peter F Ambros, et al.
The New England Journal of Medicine
|
November 25, 2005
Chromosome 1p and 11q deletions and outcome in neuroblastoma
Edward F Attiyeh, Wendy B London, Yael P Mossé, et al.
Page
of 62
Search research articles
Search
Showing results (521-530 of 612) with videos related to
Sort By:
Page
of 62
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2008
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report
Susan L Cohn, Andrew D J Pearson, Wendy B London, et al.
Pediatric Blood & Cancer
|
February 12, 2016
Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin-Embedded Tissue Samples and Are Associated With Recurrence
Navin Pinto, Jodi R Mayfield, Gordana Raca, et al.
Epidemiology (Cambridge, Mass.)
|
January 4, 2001
Residential pesticide exposure and neuroblastoma
J L Daniels, A F Olshan, K Teschke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 26, 2015
Advances in Risk Classification and Treatment Strategies for Neuroblastoma
Navin R Pinto, Mark A Applebaum, Samuel L Volchenboum, et al.
The Oncologist
|
February 18, 2017
A Phase II Randomized Trial (GO27827) of First-Line FOLFOX Plus Bevacizumab with or Without the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer
Johanna C Bendell, Howard Hochster, Lowell L Hart, et al.
Journal of Pain and Symptom Management
|
May 4, 2020
Racial and Ethnic Differences in Communication and Care for Children With Advanced Cancer
Jennifer W Mack, Hajime Uno, Clare J Twist, et al.
Clinical Pharmacology and Therapeutics
|
February 20, 2014
Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients
N Pinto, E R Gamazon, N Antao, et al.
Pediatric Blood & Cancer
|
December 19, 2013
Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: a report from the Children's Oncology Group (ANBL0621)
Elizabeth Fox, Yael P Mosse', Holly M Meany, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2008
The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report
Tom Monclair, Garrett M Brodeur, Peter F Ambros, et al.
The New England Journal of Medicine
|
November 25, 2005
Chromosome 1p and 11q deletions and outcome in neuroblastoma
Edward F Attiyeh, Wendy B London, Yael P Mossé, et al.
Page
of 62